← back to search

Pilar Martı́n

University of Miami · US
Area of research
Immunology
Research interest
Research interests include T-cell and B-cell Immunology, Immunotherapy and Immune Responses, Immune Cell Function and Interaction, and Immune Response and Inflammation.
h-index
42
citations
5,502
works
116
NIH funding
primary concept
Medicine
email

Recent publications

2024 ACC Expert Consensus Decision Pathway on Strategies and Criteria for the Diagnosis and Management of Myocarditis: A Report of the American College of Cardiology Solution Set Oversight Committee.
2025cited by 75position: contributordoi
T cells in cardiac health and disease.
2025cited by 20position: contributordoi
Restricting SLC7A5-mediated Leucine uptake in T cells prevents acute GVHD and maintains GVT response.
2025cited by 2position: contributordoi
Peripheral Ischemia Fuels Breast Cancer Via Myeloid-Skewed Hematopoiesis.
2025cited by 0position: contributordoi
T lymphocytes linking autoimmunity and cardiovascular disease in aging
The Journal of Cardiovascular Aging 2025cited by 0position: contributordoi
Apolipoprotein E-ε2 and Resistance to Atherosclerosis in Midlife: The PESA Observational Study.
2024cited by 11position: contributordoi
Update on the role of T cells in cognitive impairment.
2024cited by 9position: contributordoi
Allergic inflammation triggers dyslipidemia via IgG signalling.
2024cited by 8position: contributordoi
The inflammatory spectrum of cardiomyopathies.
2024cited by 7position: contributordoi
Lack of p38 activation in T cells increases IL-35 and protects against obesity by promoting thermogenesis.
2024cited by 4position: contributordoi
Cytosolic protein translation regulates cell asymmetry and function in early TCR activation of human CD8<sup>+</sup> T lymphocytes.
2024cited by 2position: contributordoi
BMP4 mediates myocardial inflammation and fibrosis.
2024cited by 1position: contributordoi
Current challenges and future directions for engineering extracellular vesicles for heart, lung, blood and sleep diseases
Journal of Extracellular Vesicles 2023cited by 114position: middledoi
Current challenges and future directions for engineering extracellular vesicles for heart, lung, blood and sleep diseases.
2023cited by 83position: contributordoi
Priorities in Cardio-Oncology Basic and Translational Science
JACC CardioOncology 2023cited by 41position: middledoi
Priorities in Cardio-Oncology Basic and Translational Science: GCOS 2023 Symposium Proceedings: &lt;i&gt;JACC: CardioOncology&lt;/i&gt; State-of-the-Art Review.
2023cited by 34position: contributordoi
Unraveling CD69 signaling pathways, ligands and laterally associated molecules.
2023cited by 17position: contributordoi
DECTIN-1: A modifier protein in CTLA-4 haploinsufficiency.
2023cited by 9position: contributordoi
Cardiovascular toxicity of checkpoint inhibitors: review of associated toxicity and design of the Spanish Immunotherapy Registry of Cardiovascular Toxicity.
2023cited by 3position: contributordoi
UPDATE ON THE ROLE OF T CELLS IN COGNITIVE IMPAIRMENT
2023cited by 0position: contributordoi
Allergic inflammation triggers dyslipidemia via IgG signalling
2023cited by 0position: contributordoi
Lack of p38 activation in T cells increases IL-35 production and protects against obesity by promoting thermogenesis
2023cited by 0position: contributordoi
Myocarditis following <scp>COVID</scp> ‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases
European Journal of Heart Failure 2022cited by 150position: middledoi
Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases.
2022cited by 108position: contributordoi
The impact of type 2 immunity and allergic diseases in atherosclerosis.
2022cited by 45position: contributordoi
CD69 expression on regulatory T cells protects from immune damage after myocardial infarction.
2022cited by 38position: contributordoi
Pathophysiology of Immune Checkpoint Inhibitor-Induced Myocarditis.
2022cited by 28position: contributordoi
Influence of air pollutants on circulating inflammatory cells and microRNA expression in acute myocardial infarction.
2022cited by 15position: contributordoi
The impact of type 2 immunity and allergic diseases in atherosclerosis
2022cited by 1position: contributordoi
A Novel Circulating MicroRNA for the Detection of Acute Myocarditis.
2021cited by 144position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 19 papers (2021–2025)Borja Ibáñez · Universidad Autónoma de Madrid5 papers (2022–2024)Nieves Fernández-Gallego · Spanish National Centre for Cardiovascular Research5 papers (2022–2025)Francisco Sánchez-Madrid · Universidad Autónoma de Madrid4 papers (2022–2025)Celia López-Sanz · Hospital Universitario de la Princesa4 papers (2022–2024)Rodrigo Jimenez-Saiz · Biomedical Research Networking Center on Neurodegenerative Diseases4 papers (2022–2024)Vanesa Esteban · Instituto de Salud Carlos III4 papers (2022–2024)Raquel Castillo-González · Universidad Complutense de Madrid4 papers (2022–2025)Guadalupe Sabio · Universidad de Navarra3 papers (2012–2024)Valentı́n Fuster · Spanish National Centre for Cardiovascular Research3 papers (2019–2024)Ignacio Ruiz‐Fernández · Imperial College London3 papers (2022–2024)David Obeso · Universidad San Pablo CEU3 papers (2022–2024)Bettina Heidecker · Deutsches Herzzentrum München3 papers (2021–2024)Domingo Barber · Universidad San Pablo CEU3 papers (2022–2024)Alma Villaseñor · Imperial College London3 papers (2022–2024)Fernando Rivero · Instituto de Investigación Sanitaria La Fe3 papers (2021–2022)Miguel Marcos · Centro de Investigación Biomédica en Red de Cáncer2 papers (2023–2024)Sebastian Kelle · Berlin Institute of Health at Charité - Universitätsmedizin Berlin2 papers (2022–2022)Maria M. Escribese · Medical University of Vienna2 papers (2022–2022) · 2 papers (2023–2024)